Eli Lilly can’t avoid royalties in insulin suit
21-10-2021
UK Supreme Court invalidates Eli Lilly patent relating to Cialis
27-03-2019
Michael Vi / Shutterstock.com
Teva Pharmaceuticals has failed to persuade a federal judge in Massachusetts that Eli Lilly should be penalised over its discovery search related to a patent dispute concerning a migraine treatment.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
ElI Lilly, Teva, sanctions, migraine treatment, Ajovy
